Operator
Greetings, and welcome to Global Blood Therapeutics conference call. [Operator instructions] As a reminder, this conference is being recorded. I would now like to turn this conference over to Mr. Steven Immergut.
Please go ahead, sir. You may begin.
Steven Immergut
Senior Vice President, Head of Corporate Communications, and Investor Relations
Thank you, and welcome to GBT s conference call to discuss the company s financial results for the fourth-quarter and full-year 2020 and to provide a business update. I m Steven Immergut, head of communications and investor relations. Joining me on the call are Dr. Ted Love, our president and CEO, who will provide a high-level update on our progress in the fourth quarter and over the full-year 2020; jeff Farrow, our chief financial officer, who will provide an overview of our financial results; and David Johnson, or DJ, our chief commercial officer, who will give an update on the Oxbryta launch.